Related references
Note: Only part of the references are listed.YKL-40 protein expression in the early developing human musculoskeletal system
Julia S. Johansen et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2007)
HC-gp39 contributes to chondrocyte differentiation by inducing SOX9 and type II collagen expressions
C. Jacques et al.
OSTEOARTHRITIS AND CARTILAGE (2007)
Changes in biochemical markers after lower limb fractures
Karl Stoffel et al.
CLINICAL CHEMISTRY (2007)
Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells
Anne K. Mylin et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation
Heather F. Bigg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Serum YKL-40, a new prognostic biomarker in cancer patients?
JS Johansen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Myeloma bone disease: pathophysiology and management
E Terpos et al.
ANNALS OF ONCOLOGY (2005)
Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma
JM Nigro et al.
CANCER RESEARCH (2005)
Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells
N Junker et al.
CANCER SCIENCE (2005)
The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-α
H Ling et al.
BIOCHEMICAL JOURNAL (2004)
Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion
M Abe et al.
BLOOD (2004)
The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma
E Tian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39
F Fusetti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone disease during standard chemotherapy
N Abildgaard et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase β-mediated signalling pathways
AD Recklies et al.
BIOCHEMICAL JOURNAL (2002)
YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes
F De Ceuninck et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Human cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in-situ hybridization
JR Connor et al.
OSTEOARTHRITIS AND CARTILAGE (2000)
Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma
N Abildgaard et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2000)
Share Paper
